1,337
Views
25
CrossRef citations to date
0
Altmetric
Review Articles

Shanghai Health Study (2001–2009): What was learned about benzene health effects?

& ORCID Icon
Pages 217-251 | Received 16 Jun 2017, Accepted 02 Nov 2017, Published online: 15 Dec 2017

References

  • ACGIH. 2000. American Conference of Governmental Industrial Hygienists, 7th Edition Documentation, Chemicals and Substances, Benzene. 7th Edition Documentation (ACGIH).
  • ACGIH. 2001. American Conference of Governmental Industrial Hygienists. Benzene CAS Number 71-43-2; Cincinnati, OH.
  • Aksoy M, Dincol K, Akgun T, Erdem S, Dincol G. 1971. Haematological effects of chronic benzene poisoning in 217 workers. Br J Ind Med. 28:296–302.
  • Aksoy M, Dincol K, Erdem S, Dincol G. 1972. Acute leukemia due to chronic exposure to benzene. Am J Med. 52:160–166.
  • Aksoy M, Erdem S, DinCol G. 1974. Leukemia in shoe-workers exposed chronically to benzene. Blood. 44:837–841.
  • Aksoy M. 1980. Different types of malignancies due to occupational exposure to benzene: a review of recent observations in Turkey. Environ Res. 23:181–190.
  • Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau ML, Bloomfield CD, Cazzola M, Vardiman JW. 2016. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
  • Armstrong T, Liang Y, Zhou Y, Bowes S, Wong O, Fu H, Schnatter A, Zhang C. 2010. Exposure assessment for case-control and case-case epidemiology studies based in Shanghai China: summary of methods and results. Chem Biol Interact. 184:286–289.
  • Armstrong TW, Liang Y, Hetherington Y, Bowes SM, 3rd, Wong O, Fu H, Chen M, Schnatter AR. 2011. Retrospective occupational exposure assessment for case-control and case-series epidemiology studies based in Shanghai China. J Occup Environ Hyg. 8:561–572.
  • [ATSDR] Agency for Toxic Substance and Disease Registry. 2007. Toxicological profile for benzene. USDHHS-ATSDR. August, 2007.
  • Aul C, Bowen DT, Yoshida Y. 1998. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica. 83:71–86.
  • Bain BJ. 1999. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders. Leuk Lymphoma. 34:443–449.
  • Baker RK, Kurz EU, Pyatt DW, Irons RD, Kroll DJ. 2001. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase II-alpha. Blood. 98:830–833.
  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. 1976. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 33:451–1458.
  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. 1982. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:189–199.
  • Bennett JM. 2016. Changes in the updated 2016: WHO Classification of the myelodysplastic syndromes and related myeloid neoplasms. Clin Lymphoma Myeloma Leuk. 16:607–609.
  • Blair A, Linos A, Stewart PA, Burmeister LF, Gibson R, Everett G, Schuman L, Cantor KP. 1993. Evaluation of risks for non-Hodgkin's lymphoma by occupation and industry exposures from a case-control study. Am J Ind Med. 23:301–312.
  • Bodell WJ, Pathak DN, Levay G, Ye Q, Pongracz K. 1996. Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implication for molecular dosimetry. Environ Health Perspect. 104:1189–1193.
  • Bratton SB, Lau SS, Monks TJ. 1997. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem Res Toxicol. 10:859–865.
  • Browning E. 1937. Toxicology of industrial organic solvents: summaries of published work. London: Committee on the Toxicology of Industrial Solvents, Medical Research Council, Industrial Health Research Board.
  • Browning E. 1965. Toxicity and metabolism of industrial solvents, vol. 3. Amsterdam: Elsevier.
  • Chen H, Eastmond DA. 1995. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene’s clastogenic effects. Carcinogenesis. 16:2301–2307.
  • Collins JJ, Conner P, Friedlander BR, Easterday PA, Nair RS, Braun J. 1991. A study of the hematologic effects of chronic low-level exposure to benzene. J Occup Med. 33:619–626.
  • Copley GB, Schnatter AR, Armstrong TW, Irons RD, Chen M, Wang XQ, Kerzic PJ. 2017. Hospital-based case-control study of MDS subtypes and benzene exposure in Shanghai. J Occup Environ Med. 59:349–355.
  • Crump KS. 1994. Risk of benzene-induced leukemia: a sensitivity analysis of the Pliofilm cohort with additional follow-up and new exposure estimates. J Toxicol Environ Health. 42:219–242.
  • Cuneo A, Fagioli F, Pazzi I, Tallarico A, Previati R, Piva N, Carli MG, Balboni M, Castoldi G. 1992. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leuk Res. 16:789–796.
  • Dosemeci M, Li GL, Hayes RB, Yin SN, Linet M, Chow WH, Wang YZ, Jiang ZL, Dai TR, Zhang WU. 1994. Cohort study among workers exposed to benzene in China: II. Exposure assessment. Am J Ind Med. 26:401–411.
  • Eastmond DA, Smith MT, Irons RD. 1987. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 91:85–95.
  • Fagioli F, Cuneo A, Piva N, Carli MG, Previati R, Balboni M, Tomasi P, Cariani D, Scapoli G, Castoldi G. 1992. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer. 70:77–85.
  • Foucar K, McKenna RW, Bloomfield CD, Bowers TK, Brunning RD. 1979. Therapy-related leukemia: a panmyelosis. Cancer. 43:1285–1296.
  • Frantz CE, Chen H, Eastmond DA. 1996. Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ Health Perspect. 104 Suppl 6:1319–1323.
  • Gersuk GR, Beckham C, Loken MR, Kiener P, Anderson JE, Ferrand A, Troutt AB, Ledbetter JA, Deeg HJ. 1998. A role for tumour necrosis factor-α Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 103:176–188.
  • Ghittori S, Maestri L, Fiorentino ML, Imbriani M. 1995. Evaluation of occupational exposure to benzene by urinalysis. Int Arch Occup Environ Health. 67:195–200.
  • Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, Adams GG, Bisby JA, Manuell R. 2003. Leukemia risk associated with low-level benzene exposure. Epidemiology. 14:569–577.
  • Glass DC, Schnatter AR, Tang G, Irons RD, Rushton L. 2014. Risk of myeloproliferative disease and chronic myeloid leukaemia following exposure to low-level benzene in a nested case-control study of petroleum workers. Occup Environ Med. 71:266–274.
  • Goldwater L. 1941. Disturbances in the blood following exposure to benzol. J Lab Clin Med. 26:957.
  • Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. 1982. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 60:404–411.
  • Greenburg L, Meyers R, Goldwater L, Smith H. 1939. Benzene poisoning in the retrogravure industry in New York City. J Ind Med Toxicol. 21:395–420.
  • Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899.
  • Gross SA, Irons RD, Schnatter AR, Ryder J, Wang XQ, Copley GB, Armstrong TW. 2010. A hospital-based case control study of aplastic anemia in Shanghai, China. Chem Biol Interact. 184:165–173.
  • Gross SA, Irons RD, Scott PK, Galbraith D, Wang XQ, Chen Y, Paustenbach D. 2012. A Case-Control Study of Chronic Myelomonocytic Leukemia (CMML) in Shanghai, China: evaluation of risk factors for CMML, with special focus on benzene. Arch Environ Occup Health. 67:206–218.
  • Gross SA, Zheng JH, Le AT, Kerzic PJ, Irons RD. 2006. PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34(+) hematopoietic progenitor cells. Cell Biol Toxicol. 22:229–241.
  • Gross SA, Zhu X, Bao L, Ryder J, Le A, Chen Y, Wang XQ, Irons RD. 2008. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol. 88:165–173.
  • Hajeer AH, Hutchinson IV. 2001. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 62:1191–1199.
  • Hamilton A. 1929. Industrial poisons in the United States. New York: MacMillian.
  • Hamilton A. 1931. Benzene (benzol) poisoning. General review. Arch Pathol Lab Med. 11:434.
  • Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peetes C, Falini B, Gatter KC, et al. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84:1361–1392.
  • Harrison TR. 1980. Harrison's principles of internal medicine. 9th ed. New York: McGraw-Hill.
  • Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, Li CY, Rothman N, Hoover RN, Linet MS. 1997. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine – National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 89:1065–1071.
  • Hu H. 1987. Benzene-associated myelofibrosis. Ann Intern Med. 106:171–172.
  • Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L, et al. 1997. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 72:149–153.
  • IARC. 1982. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Lyon, France: World Health Organization.
  • IARC. 2012. Benzene. In: IARC monographs on the evaluation of carcinogenic risk of chemicals to humans – chemical agents and related occupations: a review of human carcinogens. Vol. 100F. Lyon, France: IARC-WHO; p. 249–285.
  • Infante PF, Rinsky RA, Wagoner JK, Young RJ. 1977. Leukaemia in benzene workers. Lancet. 2:76–78.
  • Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. 2013. Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease. Genes Chromosomes Cancer. 52:887–894.
  • Irons RD, Gross SA, Le A, Wang XQ, Chen Y, Ryder J, Schnatter AR. 2010. Integrating WHO 2001–2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure. Chem Biol Interact. 184:30–38.
  • Irons RD, Kerzic PJ. 2014. Cytogenetics in benzene-associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum. Ann NY Acad Sci. 1310:84–88.
  • Irons RD, Le A, Bao L, Zhu X, Ryder J, Wang XQ, Ji M, Chen Y, Wu X, Lin G. 2009. Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res. 33:1599–1603.
  • Irons RD, Lv L, Gross SA, Ye X, Bao L, Wang XQ, Ryder J, Armstrong TW, Zhou Y, Miao L, et al. 2005. Chronic exposure to benzene results in a unique form of dysplasia. Leuk Res. 29:1371–1380.
  • Irons RD, Stillman WS, Colagiovanni DB, Henry VA. 1992. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA. 89:3691–3695.
  • Irons RD, Stillman WS. 1996. The process of leukemogenesis. Environ Health Perspect. 104:1239–1246.
  • Irons RD, Wang X, Gross SA, Bao L, Ryder J, Chen Y, Chen H, Sun H, Zhou J, Ji M, et al. 2006. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications. Leuk Res. 30:769–775.
  • Irons RD, Wierda D, Pfeifer RW. 1983. Immunotoxicity of benzene and its metabolites. Adv Mod Environ Toxicol. 4:37–50.
  • Irons RD. 1985a. Quinones as toxic metabolites of benzene. J Toxicol Environ Health. 16:673–678.
  • Irons R, editor. 1985b. Toxicology of the blood and bone marrow. In: Dixon RL, editor. Target organ of toxicity series. New York: Raven Press.
  • Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. 2001. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press.
  • Jandl JH. 1987. Blood: textbook of hematology. 1st ed. Boston/Toronto: Little, Brown, and Company.
  • Jandl JH. 1996a. Sideroblastic anemias. In: Blood: textbook of hematology. 2nd ed. Boston: Little, Brown, and Company; p. 305–307.
  • Jandl JH. 1996b. Aplastic anemia. Ch. 4. In: Blood: textbook of hematology. 2nd ed. Boston: Little, Brown, and Company; p. 201–250.
  • Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH. 2001. The –238 tumor necrosis factor alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 166:41–46.
  • Jordan MB, Hildeman D, Kappler J, Marrack P. 2004. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 104:735–743.
  • Kaplan SD. 1986. Update of a mortality study of workers in petroleum refineries. J Occup Med. 28:514–516.
  • Kerzic PJ, Irons RD. 2017. Distribution of chromosome breakpoints in benzene-exposed and unexposed AML patients. Environ Toxicol Pharmacol. 55:212–216.
  • Kerzic PJ, Liu WS, Pan MT, Fu H, Zhou Y, Schnatter AR, Irons RD. 2010. Analysis of hydroquinone and catechol in peripheral blood of benzene-exposed workers. Chem Biol Interact. 184:182–188.
  • Kerzic PJ, Pyatt DW, Zheng JH, Gross SA, Le A, Irons RD. 2003. Inhibition of Nf-kB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-a-induced apoptosis. Toxicology. 187:127–137.
  • Khuder SA, Youngdale MC, Bisesi MS, Schaub EA. 1999. Assessment of complete blood count variations among workers exposed to low levels of benzene. J Occup Environ Med. 41:821–826.
  • Kipen HM, Cody RP, Crump KS, Allen BC, Goldstein BD. 1988. Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers. Toxicol Ind Health. 4:411–430.
  • Klaassen C. 1991. Casarett and Doull's toxicology: the basic science of poisons. In: Klaassen C, editor. 4th ed. Toxic agents. New York (NY): McGraw-Hill.
  • Klaassen C. 2001. Casarett and Doull's toxicology: the basic science of poisons. In: Klaassen C, editor. 6th ed. General principles of toxicology. New York (NY): McGraw-Hill.
  • Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, et al. 2004. Hematoxicity in workers exposed to low levels of benzene. Science. 306:1774–1776.
  • Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. 2014. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014:149185.
  • Li G, Wang C, Xin W, Yin S. 1996. Tissue distribution of DNA adducts and their persistence in blood in mice exposed to benzene. Environ Health Perspect. 104:1337–1338.
  • Li Y-S, Zhao Y-L, Jiang Q-P, Yang C-L. 1989. Specific chromosome changes and nonoccupational exposure to potentially carcinogenic agents in acute leukemia in China. Leukemia Res. 13:367–376.
  • Liang YX, Wong O, Armstrong T, Ye XB, Miao LZ, Zhou YM, Wu QE, Qian HJ, Fu H. 2005. An overview of published benzene exposure data by industry in China, 1960–2003. Chem Biol Interact. 153–154:55–64.
  • Lichtman MA. 2016. The World Health Organization revisits the classification of the myelodysplastic syndromes: Improvement and insufficiencies. Blood Cells Mol Dis. 60:12–15.
  • Linet MS, Yin S-N, Travis LB, Li C-Y, Zhang Z-N, Li D-G, Rothman N, Li G-L, Chow W-H, Donaldson J, et al. 1996. Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Environ Health Perspect. 104:1353–1364.
  • Liu H, Liang Y, Bowes S, Xu H, Zhou Y, Armstrong TW, Wong O, Schnatter AR, Fang J, Wang L, et al. 2009. Benzene exposure in industries using or manufacturing paint in China—a literature review, 1956–2005. J Occup Environ Hyg. 6:659–670.
  • Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. 2011. Harrison’s principles of internal medicine. 18th Edition, Vol 1. New York (NY): McGraw-Hill.
  • Lv L, Kerzic P, Lin G, Schnatter AR, Bao L, Yang Y, Zou H, Fu H, Ye X, Gross SA, et al. 2007. The TNF-alpha 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene. Leuk Res. 31:1479–1485.
  • Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS. 1994. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol. 22:1102–1110.
  • McHale CM, Zhang L, Lan Q, Li G, Hubbard AE, Forrest MS, Vermeulen R, Chen J, Shen M, Rappaport SM, et al. 2009. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics. 93:343–349.
  • Medinsky MA, Schlosser PM, Bond JA. 1994. Critical issues in benzene toxicity and metabolism: the effect of interactions with other organic chemicals on risk assessment. Environ Health Perspect. 102:119–124.
  • Mele A, Stazi MA, Pulsoni A, Visani G, Monarca B, Castelli G, Rocchi L, Avvisati G, Mandelli F. 1995. Epidemiology of acute promyelocytic leukemia. Haematologica. 80:405–408.
  • Mitelman F, Brandt L, Nilsson PG. 1978. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood. 52:1229–1237.
  • Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. 1981. Chromosome pattern occupation and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 4:197–214.
  • Moran JL, Siegel D, Ross D. 1999. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA. 96:8150–8155.
  • Natelson EA. 2007. Benzene exposure and refractory sideroblastic erythropoiesis: is there an association? Am J Med Sci. 334:356–360.
  • OSHA. 1987. Occupational safety and health administration. Occupational exposure to benzene. Final Rule. Federal Register 52:34460–34578. Washington (DC): US Department of Labor.
  • OSHA. 1989. Occupational safety & health administration, Code of Federal Regulation 29 Part 1910.1028 App C, Medical Surveillance Guidelines for Benzene. V. Surveillance and Preventive Considerations, B. Hematology Guidelines. Washington (DC): US Department of Labor.
  • Pasqualetti P, Casale R, Colantonio D, Collacciani A. 1991. Occupational risk for hematological malignancies. Am J Hematol. 38:147–149.
  • Patty FA. 1948. Patty's industrial hygiene and toxicology. 1st ed. New York: Interscience Publishers Inc.
  • Paustenbach DJ, Price PS, Ollison W, Blank C, Jernigan JD, Bass RD, Peterson HD. 1992. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936–1976). J Toxicol Environ Health. 36:177–231.
  • Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. 1994. Leukemia risk associated with benzene exposure in the Pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal. 14:147–154.
  • Poynter JN, Richardson M, Roesler M, Blair CK, Hirsch B, Nguyen P, Cioc A, Cerhan JR, Warlick E. 2017. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study. Int J Cancer. 140:23–33.
  • Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. 2002. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA. 99:14925–14930.
  • Qu Q, Shore R, Li G, Jin X, Chen LC, Cohen B, Melikian AA, Eastmond D, Rappaport SM, Yin S, et al. 2002. Hematological changes among Chinese workers with a broad range of benzene exposures. Am J Ind Med. 42:275–285.
  • Rinsky RA, Hornung RW, Silver SR, Tseng CY. 2002. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment. Am J Ind Med. 42:474–480.
  • Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RJ, Okun AH, Landrigan PJ. 1987. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med. 316:1044–1050.
  • Rinsky RA, Young RJ, Smith AB. 1981. Leukemia in benzene workers. Am J Ind Med. 2:217–245.
  • Ross D. 1996. Metabolic basis of benzene toxicity. Eur J Haematol Suppl. 60:111–118.
  • Ross D. 2000. The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J Toxicol Environ Health A. 61:357–372.
  • Rothman N, Haas R, Hayes RB, Li GL, Wiemels J, Campleman S, Quintana PJ, Xi LJ, Dosemeci M, Titenko-Holland N, et al. 1995. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc Natl Acad Sci USA. 92:4069–4073.
  • Rothman N, Li GL, Dosemeci M, Bechtold WE, Marti GE, Wang YZ, Linet M, Xi LQ, Lu W, Smith MT, et al. 1996. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med. 29:236–246.
  • Ruiz MA, Augusto LG, Vassallo J, Vigorito AC, Lorand-Metze I, Souza CA. 1994. Bone marrow morphology in patients with neutropenia due to chronic exposure to organic solvents (benzene): early lesions. Pathol Res Pract. 190:151–154.
  • Rushton L, Romaniuk H. 1997. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med. 54:152–166.
  • Rushton L, Schnatter AR, Tang G, Glass DC. 2014. Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br J Cancer. 110:783–787.
  • Sahmel J, Devlin K, Burns A, Ferracini T, Ground M, Paustenbach D. 2013. An analysis of workplace exposures to benzene over four decades at a petrochemical processing and manufacturing facility (1962–1999). J Toxicol Environ Health A. 76:723–746.
  • Schattenberg DG, Stillman WS, Gruntmeir JJ, Helm KM, Irons RD, Ross D. 1994. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity. Mol Pharmacol. 46:346–351.
  • Schnatter A. 2012. Final report: pooled analysis of petroleum worker case-control studies. ExxonMobil Biomedical Sciences, Inc. Occupational and Public Health Division. Annandale, NJ, USA.
  • Schnatter AR, Armstrong TW, Nicolich MJ, Thompson FS, Katz AM, Huebner WW, Pearlman ED. 1996a. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med. 53:773–781.
  • Schnatter AR, Glass DC, Tang G, Irons RD, Rushton L. 2012. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst. 104:1724–1737.
  • Schnatter AR, Kerzic P, Zhou Y, Chen M, Nicolich MJ, Lavelle K, Armstrong TW, Bird MG, Lin L, Fu H, et al. 2010. Peripheral Blood effects in benzene-exposed workers. Chem Biol Interact. 184:174–181.
  • Schnatter AR, Nicolich MJ, Bird MG. 1996b. Determination of leukemogenic benzene exposure concentrations: refined analyses of the Pliofilm cohort. Risk Anal. 16:833–840.
  • Schultz JC, Shahidi NT. 1994. Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood from patients with aplastic anemia. Am J Hematol. 45:32–38.
  • Selling L. 1916. Benzol a leukotoxine. Studies on the degeneration of the blood and hematopoietic organs. Johns Hopkins Hosp Rep.
  • Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, Borok R, Showel J, Gregory S, Rifkin S, et al. 1996. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 20:891–900.
  • Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A. 1999. A common functional polymorphism (C–>A substitution at position –863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 8:1443–1449.
  • Smith MT, Zhang L, Jeng M, Wang Y, Guo W, Duramad P, Hubbard AE, Hofstadler G, Holland NT. 2000. Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis. 21:1485–1490.
  • Smith MT, Zhang L, McHale CM, Skibola CF, Rappaport SM. 2011. Benzene, the exposome and future investigations of leukemia etiology. Chem Biol Interact. 192:155–159.
  • Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Wiemels J, Dosemeci M, Titenko-Holland N, Xi L, Kolachana P, et al. 1998. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 58:2176–2181.
  • Smith MT. 1996. Overview of benzene-induced aplastic anaemia. Eur J Haematol Suppl. 60:107–110.
  • Smith MT. 1999. Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci USA. 96:7624–7626.
  • Smith MT. 2010. Advances in understanding benzene health effects and susceptibility. Annu Rev Public Health. 31:133–148, 2 p following 148.
  • Snyder R, Hedli CC. 1996. An overview of benzene metabolism. Environ Health Perspect. 104 Suppl 6:1165–1171.
  • Song Y, Du X, Hao F, Gu X, Zhang Z, Zhang S, Li C, Li H, Ma J. 2010. Immunosuppressive therapy of cyclosporine A for severe benzene-induced hematopoietic disorders and a 6-month follow up. Chem Biol Interact. 186:96–102.
  • Stedman TL. 2002. The American Heritage Stedman’s Medical Dictionary. 2nd revised ed. Boston: Houghton Mifflin.
  • Stillman WS, Varella-Garcia M, Gruntmeir JJ, Irons RD. 1997. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia. 11:1540–1545.
  • Stillman WS, Varella-Garcia M, Irons RD. 1999. The benzene metabolites hydroquinone and catechol act in synergy to induce dose-dependent hypoploidy and –5q31 in a human cell line. Leuk Lymphoma. 35:269–281.
  • Stillman WS, Varella-Garcia M, Irons RD. 2000. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34 + CD19– bone marrow cells. Exp Hematol. 28:169–176.
  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. 2008. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Geneva, Switzerland: WHO Press.
  • Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW. 1992. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 52:797–802.
  • Travis LB, Li CY, Zhang ZN, Li DG, Yin SN, Chow WH, Li GL, Dosemeci M, Blot W, Fraumeni JF, Jr., et al. 1994. Hematopoietic malignancies and related disorders among benzene-exposed workers in China. Leuk Lymphoma. 14:91–102.
  • Twerdok LE, Rembish SJ, Trush MA. 1992. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol. 112:273–281.
  • Valentine JL, Lee SS, Seaton MJ, Asgharian B, Farris G, Corton JC, Gonzalez FJ, Medinsky MA. 1996. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol. 141:205–213.
  • van den Berghe EA, Mecucci C, Delannoy A, Van den Berghe H. 1990. Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome. Cancer Genet Cytogenet. 48:49–52.
  • Vigliani EC, Saita G. 1964. Benzene and leukemia. N Engl J Med. 271:872–876.
  • Wallace L, Pellizzari E, Hartwell TD, Perritt R, Ziegenfus R. 1987. Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health. 42:272–279.
  • Wallace L. 1996. Environmental exposure to benzene: an update. Environ Health Perspect. 104 Suppl 6:1129–1136.
  • Wan J, Shi J, Hui L, Wu D, Jin X, Zhao N, Huang W, Xia Z, Hu G. 2002. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect. 110:1213–1218.
  • Wang W, Li C, Long Y, Zhan C, Xiang C. 2002. Study on the relationship between glutathione S transferase mu gene deletion and leukemia in workers exposed to benzene. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 20:38–41.
  • Williams PR, Paustenbach DJ. 2003. Reconstruction of benzene exposure for the Pliofilm cohort (1936–1976) using Monte Carlo techniques. J Toxicol Environ Health A. 66:677–781.
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 94:3195–3199.
  • Wong O, Fu H. 2005. Exposure to benzene and non-Hodgkin lymphoma, an epidemiologic overview and an ongoing case-control study in Shanghai. Chem Biol Interact. 153–154:33–41.
  • Wong O, Harris F, Armstrong TW, Hua F. 2010a. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Chem Biol Interact. 184:112–128.
  • Wong O, Harris F, Armstrong TW, Hua F. 2010b. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Chem Biol Interact. 184:129–146.
  • Wong O, Harris F, Wang Y, Fu H. 2010c. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of personal characteristics, lifestyle, and environmental risk factors by subtypes of the WHO classification. J Occup Environ Med. 52:39–53.
  • Wong O, Harris F, Yiying W, Hua F. 2009. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification. Regul Toxicol Pharmacol. 55:340–352.
  • Wong O. 1995. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ Med. 52:380–384.
  • Wong O. 1999. A critique of the exposure assessment in the epidemiologic study of benzene-exposed workers in China conducted by the Chinese Academy of Preventive Medicine and the US National Cancer Institute. Regul Toxicol Pharmacol. 30:259–267.
  • Wong O. 2003a. Regulation of occupational exposures in China. Regul Toxicol Pharmacol. 38:109–111.
  • Wong O. 2003b. Letter from Shanghai. Occup Environ Med. 60:223.
  • Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP, Lin MT, Cheng AL, Lin JT. 2004. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer. 110:695–700.
  • Yager JW, Eastmond DA, Robertson ML, Paradisin WM, Smith MT. 1990. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res. 50:393–399.
  • Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Li CY, Zhang ZN, Li DG, Chow WH, et al. 1996. A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med. 29:227–235.
  • Yin SN, Linet MS, Hayes RB, Li GL, Dosemeci M, Wang YZ, Chow WH, Jiang ZL, Wacholder S, Zhang WU, et al. 1994. Cohort study among workers exposed to benzene in China: I. General methods and resources. Am J Ind Med. 26:383–400.
  • Young NS. 2000. Aplastic Anemia. In: Young NS, editor. The bone marrow failure syndromes. Philadelphia, PA: W. B. Saunders; p. 1–46.
  • Yu R, Weisel CP. 1996. Measurement of benzene in human breath associated with an environmental exposure. J Expo Anal Environ Epidemiol. 6:261–277.
  • Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, et al. 2005. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 29:141–152.
  • Zhang L, Rothman N, Wang Y, Hayes RB, Li G, Dosemeci M, Yin S, Kolachana P, Titenko-Holland N, Smith MT. 1998. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis. 19:1955–1961.
  • Zheng JH, Pyatt DW, Gross SA, Le A, Kerzic PJ, Irons RD. 2004. Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells. Leukemia. 18:1296–1304.
  • Zoloth SR, Michaels DM, Villalbi JR, Lacher M. 1986. Patterns of mortality among commercial pressmen. J Natl Cancer Inst. 76:1047–1051.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.